Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.06
SNN's Cash to Debt is ranked lower than
58% of the 509 Companies
in the Global Medical Devices industry.

( Industry Median: 2.15 vs. SNN: 0.06 )
SNN' s 10-Year Cash to Debt Range
Min: 0.06   Max: 2.58
Current: 0.06

0.06
2.58
Equity to Asset 0.55
SNN's Equity to Asset is ranked higher than
63% of the 472 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SNN: 0.55 )
SNN' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.7
Current: 0.55

0.34
0.7
Interest Coverage 21.40
SNN's Interest Coverage is ranked higher than
55% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 365.56 vs. SNN: 21.40 )
SNN' s 10-Year Interest Coverage Range
Min: 7.79   Max: 94
Current: 21.4

7.79
94
F-Score: 6
Z-Score: 5.08
M-Score: -2.65
WACC vs ROIC
7.08%
10.03%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 16.26
SNN's Operating margin (%) is ranked higher than
90% of the 485 Companies
in the Global Medical Devices industry.

( Industry Median: 4.94 vs. SNN: 16.26 )
SNN' s 10-Year Operating margin (%) Range
Min: 12.6   Max: 23.22
Current: 16.26

12.6
23.22
Net-margin (%) 10.89
SNN's Net-margin (%) is ranked higher than
89% of the 485 Companies
in the Global Medical Devices industry.

( Industry Median: 2.98 vs. SNN: 10.89 )
SNN' s 10-Year Net-margin (%) Range
Min: 8.9   Max: 26.81
Current: 10.89

8.9
26.81
ROE (%) 12.30
SNN's ROE (%) is ranked higher than
87% of the 476 Companies
in the Global Medical Devices industry.

( Industry Median: 3.46 vs. SNN: 12.30 )
SNN' s 10-Year ROE (%) Range
Min: 12.67   Max: 47.17
Current: 12.3

12.67
47.17
ROA (%) 7.30
SNN's ROA (%) is ranked higher than
87% of the 512 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. SNN: 7.30 )
SNN' s 10-Year ROA (%) Range
Min: 7.79   Max: 22.64
Current: 7.3

7.79
22.64
ROC (Joel Greenblatt) (%) 36.22
SNN's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 509 Companies
in the Global Medical Devices industry.

( Industry Median: 5.54 vs. SNN: 36.22 )
SNN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 29.57   Max: 70.26
Current: 36.22

29.57
70.26
Revenue Growth (3Y)(%) 2.50
SNN's Revenue Growth (3Y)(%) is ranked higher than
71% of the 342 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. SNN: 2.50 )
SNN' s 10-Year Revenue Growth (3Y)(%) Range
Min: 1   Max: 37.2
Current: 2.5

1
37.2
EBITDA Growth (3Y)(%) 0.40
SNN's EBITDA Growth (3Y)(%) is ranked higher than
75% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. SNN: 0.40 )
SNN' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -2.4   Max: 36.3
Current: 0.4

-2.4
36.3
EPS Growth (3Y)(%) -4.90
SNN's EPS Growth (3Y)(%) is ranked higher than
74% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: -2.00 vs. SNN: -4.90 )
SNN' s 10-Year EPS Growth (3Y)(%) Range
Min: -8.2   Max: 57.4
Current: -4.9

-8.2
57.4
» SNN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

SNN Guru Trades in Q1 2014

David Dreman 78,118 sh (+17.20%)
Jim Simons 84,200 sh (+4.47%)
Pioneer Investments 38,402 sh (unchged)
John Hussman 19,500 sh (unchged)
Ken Fisher 994,111 sh (-5.85%)
» More
Q2 2014

SNN Guru Trades in Q2 2014

Louis Moore Bacon 30,000 sh (New)
Mario Gabelli 9,650 sh (New)
Jim Simons 143,000 sh (+69.83%)
Ken Fisher 1,361,425 sh (+36.95%)
Steven Cohen 204,800 sh (unchged)
John Hussman 19,500 sh (unchged)
David Dreman 74,877 sh (-4.15%)
Pioneer Investments 33,902 sh (-11.72%)
» More
Q3 2014

SNN Guru Trades in Q3 2014

Mario Gabelli 15,350 sh (+59.07%)
Louis Moore Bacon 40,000 sh (+33.33%)
Jim Simons 171,800 sh (+20.14%)
John Hussman 19,500 sh (unchged)
Pioneer Investments 34,059 sh (unchged)
Steven Cohen Sold Out
David Dreman 74,325 sh (-0.74%)
Ken Fisher 973,153 sh (-28.52%)
» More
Q4 2014

SNN Guru Trades in Q4 2014

Pioneer Investments 84,570 sh (+148.30%)
John Hussman 48,750 sh (unchged)
Louis Moore Bacon Sold Out
Ken Fisher 2,291,837 sh (-5.80%)
Mario Gabelli 31,875 sh (-16.94%)
David Dreman 148,777 sh (-19.93%)
Jim Simons 343,850 sh (-19.94%)
» More
» Details

Insider Trades

Latest Guru Trades with SNN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 34.50
SNN's P/E(ttm) is ranked higher than
83% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 34.50 )
SNN' s 10-Year P/E(ttm) Range
Min: 10.22   Max: 44.27
Current: 34.5

10.22
44.27
Forward P/E 15.11
SNN's Forward P/E is ranked higher than
96% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 15.11 )
N/A
PE(NRI) 34.40
SNN's PE(NRI) is ranked higher than
85% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 34.40 )
SNN' s 10-Year PE(NRI) Range
Min: 11.42   Max: 45.28
Current: 34.4

11.42
45.28
P/B 4.10
SNN's P/B is ranked higher than
62% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. SNN: 4.10 )
SNN' s 10-Year P/B Range
Min: 0.55   Max: 8.19
Current: 4.1

0.55
8.19
P/S 3.75
SNN's P/S is ranked higher than
82% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 4.16 vs. SNN: 3.75 )
SNN' s 10-Year P/S Range
Min: 1.67   Max: 4.76
Current: 3.75

1.67
4.76
PFCF 53.82
SNN's PFCF is ranked higher than
79% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 53.82 )
SNN' s 10-Year PFCF Range
Min: 12.57   Max: 190.33
Current: 53.82

12.57
190.33
POCF 25.19
SNN's POCF is ranked higher than
83% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 1303.50 vs. SNN: 25.19 )
SNN' s 10-Year POCF Range
Min: 8.22   Max: 38.07
Current: 25.19

8.22
38.07
EV-to-EBIT 26.43
SNN's EV-to-EBIT is ranked higher than
85% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 151.63 vs. SNN: 26.43 )
SNN' s 10-Year EV-to-EBIT Range
Min: 8.8   Max: 51.5
Current: 26.43

8.8
51.5
PEG 13.76
SNN's PEG is ranked higher than
91% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 13.76 )
SNN' s 10-Year PEG Range
Min: 0.33   Max: 28.98
Current: 13.76

0.33
28.98
Shiller P/E 28.13
SNN's Shiller P/E is ranked higher than
93% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 28.13 )
SNN' s 10-Year Shiller P/E Range
Min: 16.4   Max: 53.08
Current: 28.13

16.4
53.08
Current Ratio 2.10
SNN's Current Ratio is ranked higher than
64% of the 508 Companies
in the Global Medical Devices industry.

( Industry Median: 2.58 vs. SNN: 2.10 )
SNN' s 10-Year Current Ratio Range
Min: 0.84   Max: 2.42
Current: 2.1

0.84
2.42
Quick Ratio 1.08
SNN's Quick Ratio is ranked higher than
54% of the 508 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. SNN: 1.08 )
SNN' s 10-Year Quick Ratio Range
Min: 0.47   Max: 1.35
Current: 1.08

0.47
1.35
Days Inventory 354.48
SNN's Days Inventory is ranked higher than
56% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 169.25 vs. SNN: 354.48 )
SNN' s 10-Year Days Inventory Range
Min: 211.9   Max: 336.53
Current: 354.48

211.9
336.53
Days Sales Outstanding 79.87
SNN's Days Sales Outstanding is ranked higher than
72% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 82.25 vs. SNN: 79.87 )
SNN' s 10-Year Days Sales Outstanding Range
Min: 73.2   Max: 97.4
Current: 79.87

73.2
97.4

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.55
SNN's Dividend Yield is ranked higher than
80% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. SNN: 2.55 )
SNN' s 10-Year Dividend Yield Range
Min: 0.56   Max: 2.27
Current: 2.55

0.56
2.27
Dividend Payout 0.78
SNN's Dividend Payout is ranked higher than
91% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 0.78 )
SNN' s 10-Year Dividend Payout Range
Min: 0.13   Max: 4.43
Current: 0.78

0.13
4.43
Dividend growth (3y) 14.50
SNN's Dividend growth (3y) is ranked higher than
87% of the 118 Companies
in the Global Medical Devices industry.

( Industry Median: 6.30 vs. SNN: 14.50 )
SNN' s 10-Year Dividend growth (3y) Range
Min: -54   Max: 19.6
Current: 14.5

-54
19.6
Yield on cost (5-Year) 5.68
SNN's Yield on cost (5-Year) is ranked higher than
95% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. SNN: 5.68 )
SNN' s 10-Year Yield on cost (5-Year) Range
Min: 1.07   Max: 4.96
Current: 5.68

1.07
4.96
Share Buyback Rate 0.10
SNN's Share Buyback Rate is ranked higher than
87% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: -1.40 vs. SNN: 0.10 )
SNN' s 10-Year Share Buyback Rate Range
Min: 23.3   Max: -0.6
Current: 0.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 62.32
SNN's Price/Tangible Book is ranked lower than
62% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 8.20 vs. SNN: 62.32 )
SNN' s 10-Year Price/Tangible Book Range
Min: 4.14   Max: 166.63
Current: 62.32

4.14
166.63
Price/DCF (Projected) 2.10
SNN's Price/DCF (Projected) is ranked higher than
88% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 2.10 )
SNN' s 10-Year Price/DCF (Projected) Range
Min: 1.04   Max: 14.88
Current: 2.1

1.04
14.88
Price/Median PS Value 1.32
SNN's Price/Median PS Value is ranked higher than
67% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 1.30 vs. SNN: 1.32 )
SNN' s 10-Year Price/Median PS Value Range
Min: 0.65   Max: 4.72
Current: 1.32

0.65
4.72
Price/Graham Number 9.55
SNN's Price/Graham Number is ranked higher than
72% of the 560 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 9.55 )
SNN' s 10-Year Price/Graham Number Range
Min: 0.93   Max: 10
Current: 9.55

0.93
10
Earnings Yield (Greenblatt) 3.80
SNN's Earnings Yield (Greenblatt) is ranked higher than
82% of the 491 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. SNN: 3.80 )
SNN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.9   Max: 11.4
Current: 3.8

1.9
11.4
Forward Rate of Return (Yacktman) 2.82
SNN's Forward Rate of Return (Yacktman) is ranked higher than
77% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.98 vs. SNN: 2.82 )
SNN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 1.9   Max: 66.6
Current: 2.82

1.9
66.6

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:SN..UK, NPW1.Germany, NPWA.Germany, SNNUF.USA,
Smith & Nephew PLC was incorporated on February 17, 1937. The Company develops, manufactures, markets and sells medical devices. The Company is organized into business segments namely Advanced Surgical Devices and Advanced Wound Management. The Advanced Surgical Devices offers Orthopaedic Reconstruction which includes Hip Implants, Knee Implants and ancillary products such as bone cement and mixing systems used in cemented reconstruction joint surgery, Trauma & Extremities consisting of internal and external devices used in the stabilisation of severe fractures and deformity correction procedures, Sports Medicine Joint Repair, which offers surgeons a various instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, Arthroscopy Enabling Technologies which offer healthcare providers various technologies such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualisation inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. The Advanced Wound Management segment offers Advanced Wound Care includes products for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns and post-operative wounds, Advanced Wound Devices consists of traditional and single-use Negative Pressure Wound Therapy and hydrosurgery systems, Advanced Wound Bioactives includes biologics and other bioactive technologies that provide approaches to debridement and dermal repair/regeneration. The Company operates across the world and is subject to legislation, including anti-bribery and corruption and data protection, in each country in which it operates.
» More Articles for SNN

Headlines

Articles On GuruFocus.com
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
Sintana Energy Reports on Execution of Drilling Rig Contract Dec 11 2014 
3 Dividend Kings From The U.K. I Love To Buy Aug 21 2014 
Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
5 Highly Predictable Mid-/Large-Caps with ROC Over 15% Apr 21 2012 
The Best Dividends on April 18, 2012 Apr 18 2012 
5 Healthcare Stocks to Consider Today Mar 21 2012 
medical Feb 29 2012 
Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 
comment on SNN Nov 08 2011 


More From Other Websites
Smith & Nephew Advanced Wound Management Supports Wound Care Nurses Apr 13 2015
Smith & Nephew Advanced Wound Management Supports Wound Care Nurses Apr 13 2015
AstraZeneca plc vs Smith & Nephew plc vs Indivior PLC: Which Healthcare Stock Should You Buy? Apr 09 2015
Southwest scores federal funding for training facility Apr 07 2015
Growing body of evidence supports use of PICO◊ Negative Pressure Wound Therapy to address... Mar 31 2015
Growing body of evidence supports use of PICO◊ Negative Pressure Wound Therapy to address... Mar 31 2015
Smith & Nephew to Expand on Q-FIX All-Suture Anchor Launch - Analyst Blog Mar 30 2015
Is The Reward Worth The Risk With BT Group plc, Admiral Group PLC, Smith & Nephew plc And Associated... Mar 30 2015
New Q-FIX™ All-Suture Anchor from Smith & Nephew provides surgeons the pull-out strength of a hard... Mar 25 2015
SMITH & NEPHEW PLC Financials Mar 14 2015
Keep An Eye On Smith & Nephew plc & Shire plc Now! Mar 04 2015
Smith & Nephew Acquires Colombian Distributor Mar 03 2015
BUZZ-Smith & Nephew: top FTSE loser as Stryker share buyback dents M&A hopes Mar 03 2015
Acquisition of Colombian distributor ECC Mar 03 2015
Don’t Make These Basic Mistakes With BHP Billiton plc, Smith & Nephew plc And Tungsten Corp PLC Feb 25 2015
Smith & Nephew attains Great Place to Work accreditation in Italy Feb 23 2015
Current report regarding a transaction of the kind listed in Art. 225 of Law No. 297/2004 -... Feb 17 2015
Current report regarding a transaction of the kind listed in Art. 225 of Law No. 297/2004 Feb 17 2015
The report regarding the subscriptions of shares within the share capital increase of Societatea... Feb 17 2015
Smith & Nephew's Shares Are Risky, Despite the Company's Strong Outlook Feb 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK